POGO

ARIZONA PBS AND PRIMAVERA ONLINE SCHOOL ANNOUNCE WINNERS OF STATEWIDE K-5 WRITING CONTEST

Retrieved on: 
Thursday, June 15, 2023
Online, Mass communication, Primavera, 3D, Journalism, KAET, ThinkPad, Walter Cronkite School of Journalism and Mass Communication, Primavera Online High School, K-12, Student, Reading, Lenovo, POGO, Tutoring

CHANDLER, Ariz., June 15, 2023 /PRNewswire/ -- The winners of this year's Arizona PBS Writing Contest, sponsored by Primavera Online School, a tuition-free, public charter school for grades K-12, have been announced.

Key Points: 
  • CHANDLER, Ariz., June 15, 2023 /PRNewswire/ -- The winners of this year's Arizona PBS Writing Contest, sponsored by Primavera Online School, a tuition-free, public charter school for grades K-12, have been announced.
  • The children's writing contest, which was open to all elementary school students across Arizona, asked students to imagine what the future of school might be like by writing and/or illustrating a fiction or nonfiction story.
  • "We are so pleased to partner with Arizona PBS and sponsor this year's writing contest that asked students to imagine what the future of school might look like," said Jessica Pagoulatos, Executive Director at Primavera Online.
  • "As one of the first in Arizona to enter the online space, we at Primavera like to think of our school as being at the forefront of what school will be like in the future."

Global Agriculture Sensors Market Report 2022-2027: Key Drivers are Subscription Models, Data Analytics through Sensors, Integration with Emerging Technologies, Robots and Drones, & Blockchain

Retrieved on: 
Monday, May 8, 2023
Partnership, Food, Information technology, Farmer, Agriculture, COVID-19, Water, Research, Attention, Government, Soil, Machine learning, K-water, Growth, POGO, Region, Salt, Nitrogen, Benchmarking, Water resources, Globalization

New entrants are penetrating the market, backed up by government funding and corporate investments, which is one of the major opportunities in the global agriculture sensors market.

Key Points: 
  • New entrants are penetrating the market, backed up by government funding and corporate investments, which is one of the major opportunities in the global agriculture sensors market.
  • Moreover, agriculture sensors also help in enhancing yield quality due to the timely detection of pest infestation and diseases.
  • The global agriculture sensors market in the application segment is expected to be dominated by the crop monitoring segment.
  • Competitive Strategy: Key players in the agriculture sensors market analyzed and profiled in the study involve agriculture sensor manufacturers.

Global Agriculture Sensors Market Report 2023: A $7.5+ Billion Industry by 2027 - Increased Emphasis on Climate-Smart Agriculture Bodes well for the Sector - ResearchAndMarkets.com

Retrieved on: 
Friday, May 5, 2023
Agriculture, Natural Resources, Partnership, Food, Information technology, Farmer, COVID-19, Water, Research, Attention, Government, Soil, Machine learning, K-water, Growth, POGO, Region, Salt, Nitrogen, Benchmarking, Water resources, Globalization

The global agriculture sensors market was valued at $3,599.5 million in 2022 and is expected to reach $7,598.6 million in 2027, following a CAGR of 16.12% during 2022-2027.

Key Points: 
  • The global agriculture sensors market was valued at $3,599.5 million in 2022 and is expected to reach $7,598.6 million in 2027, following a CAGR of 16.12% during 2022-2027.
  • New entrants are penetrating the market, backed up by government funding and corporate investments, which is one of the major opportunities in the global agriculture sensors market.
  • Moreover, agriculture sensors also help in enhancing yield quality due to the timely detection of pest infestation and diseases.
  • The global agriculture sensors market in the application segment is expected to be dominated by the crop monitoring segment.

The Self Monitoring Blood Glucose Devices Market Is Set To Reach $20 Billion By 2027, Driven By Rising Diabetes Cases - By The Business Research Company

Retrieved on: 
Monday, January 16, 2023
Chek, Roche, Glucagon (medication), COVID-19, International Diabetes Federation, IDF, Government, Risk, Death, Growth, Glucose, Diabetes, Glucagon, Patient, Pharmacy, Kroger, Incidence, Life, POGO, Pharmaceutical industry, Medical device

 LONDON, Jan. 16, 2023 /PRNewswire/ -- The increased incidence of diabetes will support the growth of the self-monitoring blood glucose (SMBG) devices market. For example, in December 2022, according to the International Diabetes Federation (IDF) (a provider of the latest figures, nformation and projections on diabetes worldwide) Diabetes Atlas 2022, approximately 537 million adults (20-79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. Diabetes caused 6.7 million deaths and causing at least $966 billion dollars in health expenditure, 9% of total spending on adults. More than 1.2 million children and adolescents (0-19 years) are living with type 1 diabetes. 541 million adults are at increased risk of developing type 2 diabetes.  Thus, the increased incidence of diabetes will drive the self-monitoring blood glucose (SMBG) devices market growth.

Key Points: 
  • Thus, the increased incidence of diabetes will drive the self-monitoring blood glucose (SMBG) devices market growth.
  • The self-monitoring blood glucose (SMBG) devices market share is expected to grow to $20.29 billion in 2027 at a CAGR of 8.6%.
  • As per the self monitoring blood glucose (SMBG) devices market forecast, major companies operating in the self-monitoring blood glucose (SMBG) devices market are focused on developing new technological solutions to strengthen their position in the self-monitoring blood glucose (SMBG) devices market.
  • North America was the largest region in the self-monitoring blood glucose (SMBG) devices market and was worth $5.45 billion in 2022, according to the self monitoring blood glucose (SMBG) devices market analysis.

The Self Monitoring Blood Glucose Devices Market Is Set To Reach $20 Billion By 2027, Driven By Rising Diabetes Cases - By The Business Research Company

Retrieved on: 
Monday, January 16, 2023
Chek, Roche, Glucagon (medication), COVID-19, International Diabetes Federation, IDF, Government, Risk, Death, Growth, Glucose, Diabetes, Glucagon, Patient, Pharmacy, Kroger, Incidence, Life, POGO, Pharmaceutical industry, Medical device

LONDON, Jan. 16, 2023 /PRNewswire/ -- The increased incidence of diabetes will support the growth of the self-monitoring blood glucose (SMBG) devices market. For example, in December 2022, according to the International Diabetes Federation (IDF) (a provider of the latest figures, nformation and projections on diabetes worldwide) Diabetes Atlas 2022, approximately 537 million adults (20-79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. Diabetes caused 6.7 million deaths and causing at least $966 billion dollars in health expenditure, 9% of total spending on adults. More than 1.2 million children and adolescents (0-19 years) are living with type 1 diabetes. 541 million adults are at increased risk of developing type 2 diabetes.  Thus, the increased incidence of diabetes will drive the self-monitoring blood glucose (SMBG) devices market growth.

Key Points: 
  • Thus, the increased incidence of diabetes will drive the self-monitoring blood glucose (SMBG) devices market growth.
  • The self-monitoring blood glucose (SMBG) devices market share is expected to grow to $20.29 billion in 2027 at a CAGR of 8.6%.
  • As per the self monitoring blood glucose (SMBG) devices market forecast, major companies operating in the self-monitoring blood glucose (SMBG) devices market are focused on developing new technological solutions to strengthen their position in the self-monitoring blood glucose (SMBG) devices market.
  • North America was the largest region in the self-monitoring blood glucose (SMBG) devices market and was worth $5.45 billion in 2022, according to the self monitoring blood glucose (SMBG) devices market analysis.

Delta Discussed its Coral Restoration Initiative, High Temperature-tolerant Coral Genes and Blue Carbon Topics with World-class Experts in the Action Hub of the COP27 Blue Zone

Retrieved on: 
Friday, November 18, 2022
Carbon, Environmental Justice Foundation, Renewable energy, Ecosystem, Automation, ICT, Ecology, Conference, NFT, Dow Jones, Climate change, Blue Zone, EV, Partnership, POGO, DJSI, Delta Electronics, United Nations Framework Convention on Climate Change, Observation, National Museum of Marine Biology and Aquarium, RD, Biophysical environment, FAB, COP27, Research, EJF, Biodiversity, Electronics, CDP, Conference of the Parties, Marine biology, Seaweed, Asia University, Delta

High temperature-tolerant coral genes and blue carbon ecosystems were also part of the event discussion, which overall received enthusiastic responses from international opinion leaders.

Key Points: 
  • High temperature-tolerant coral genes and blue carbon ecosystems were also part of the event discussion, which overall received enthusiastic responses from international opinion leaders.
  • Different from the traditional conferences, Action Hub is held in a semi-open space in the Blue Zone to allow participants to participate freely.
  • Meanwhile, the Delta Electronics Foundation set up a booth in the Blue Zone during COP27 to display coral restoration equipment, which also facilitated the exchange of ideas with several international climate advocates.
  • Over the years, Delta has been recognized by numerous international awards that have proven our achievements in operations, innovation, and sustainability.

Intuity Medical and embecta Launch Commercial Collaboration, Expanding Access to Self-Management Innovations for People With Diabetes

Retrieved on: 
Monday, November 7, 2022
Leadership, Company, Becton, Self-management, GLOBE, FDA, Senior, Quality of life, Glucose, CEO, EMBC, Physician, Becton, Dickinson and Company headquarters, Life, NASDAQ, Health, Diabetes, POGO, Automatic, Pharmaceutical industry, Medical device

Intuity Medical is a medical technology company focused on the development and commercialization of seamless and intuitive blood glucose monitoring solutions.

Key Points: 
  • Intuity Medical is a medical technology company focused on the development and commercialization of seamless and intuitive blood glucose monitoring solutions.
  • We are excited to partner with an established leader like embecta that has such extensive experience serving people with diabetes, said George Zamanakos, President and CEO of Intuity Medical.
  • Automatic blood glucose monitoring is transforming this vital aspect of self-management into something truly seamless and simple for people with diabetes.
  • Intuity Medical, Inc. is a commercial-stage medical technology company focused on developing innovative solutions to improve the health and quality of life of people with diabetes.

Automatic Blood Glucose Monitoring Pioneer Intuity Medical Appoints Industry Veteran George Zamanakos President and CEO

Retrieved on: 
Thursday, October 27, 2022
LifeScan, McKinsey & Company, Growth, Johnson & Johnson, Diabetes, Automatic, Leadership, FDA, Continuous glucose monitor, Quality of life, CEO, Health, Physics, Anderson, POGO, Pharmaceutical industry, Dexcom, California Institute of Technology

FREMONT, Calif., Oct. 27, 2022 /PRNewswire/ -- Intuity Medical, Inc., a medical technology company with the mission of making life with diabetes easier, today announced the appointment of George Zamanakos as President and CEO.

Key Points: 
  • FREMONT, Calif., Oct. 27, 2022 /PRNewswire/ -- Intuity Medical, Inc., a medical technology company with the mission of making life with diabetes easier, today announced the appointment of George Zamanakos as President and CEO.
  • Zamanakos succeeds Emory Anderson, who led the company over the past 14 years in the development and last year's launch of its POGO Automatic Blood Glucose Monitoring System.
  • "On behalf of the board, we are pleased to welcome George to lead Intuity Medical as we venture into the next phase of the company's development.
  • Intuity Medical's POGO Automatic Blood Glucose Monitoring System is the only FDA-cleared automatic blood glucose monitoring system that lances and collects blood in just one step with 10-test cartridge technology, ending the need to individually load lancets and test strips (as required by other blood glucose meters).

The Galaxy XCover6 Pro brings rugged business performance to Verizon

Retrieved on: 
Thursday, October 20, 2022
Vodafone Global Enterprise, Samsung Galaxy Xcover 2, Payment card, Samsung Knox, Human voice, Somatosensory system, IP68, Samsung Galaxy, Dex, Water, Rain, RootMetrics, Solution, VZ, TB, Facial recognition, Business marketing, NYSE, OS, Software, BlueJeans, Tax, UI, GLOBE, Smart, Government, Sand, Hand, Organization, ECPD, Mechanoreceptor, HDMI, Dust, Contract, Voice over IP, POGO, Technology, Temperature, HP EliteBook, Samsung, High-pass filter, State, ORF, Weather, Sale, Fresh water, Verizon (mobile network), RSS, Nasdaq, Mobile device management, Face, G, Galaxy, Sensitivity, Mobile phone, Cable television, Video game console, Telescopic sight, Health insurance, Tissue paper, Verizon Communications

This means the Galaxy XCover6 Pro is available for $49.99 for Global Enterprise, Public Sector2 and Business Market customers.

Key Points: 
  • This means the Galaxy XCover6 Pro is available for $49.99 for Global Enterprise, Public Sector2 and Business Market customers.
  • Verizon customers who purchase the Samsung Galaxy XCover6 Pro will have access to BlueJeans , and Verizon Mobile Device Management apps pre-installed4.
  • The Samsung Galaxy XCover6 Pro supports Verizon One Talk Enhanced Dialer and Mission Critical Push to Talk (MCPTT) 5.
  • The Galaxy XCover6 Pro is a breakthrough in rugged performance and is powered by an enhanced 6nm Octa-Core advanced processor to deliver supercharged speeds to help employees get more done.

Discount Pricing for POGO Automatic® Blood Glucose Monitoring System Now Offered Through Costco Member Prescription Program

Retrieved on: 
Tuesday, September 20, 2022
Health, The Fruit & Veggie Prescription Program, Medicare, Interest, FDA, CMPP, Life, Pharmacy, Person, Diabetes, Automatic, Program, CEO, Quality of life, Solution, Insurance, POGO, Silicon, Multimedia, Pharmaceutical industry, Health insurance, Medical device, Online shopping, Costco, Medicaid

FREMONT, Calif., Sept. 20, 2022 /PRNewswire/ -- Intuity Medical, Inc., a commercial-stage medical technology and digital health company focused on making life with diabetes easier, announced today that the POGO Automatic Blood Glucose Monitoring System and POGO Automatic Test Cartridges are now available with discount pricing through the Costco Member Prescription Program (CMPP).

Key Points: 
  • FREMONT, Calif., Sept. 20, 2022 /PRNewswire/ -- Intuity Medical, Inc., a commercial-stage medical technology and digital health company focused on making life with diabetes easier, announced today that the POGO Automatic Blood Glucose Monitoring System and POGO Automatic Test Cartridges are now available with discount pricing through the Costco Member Prescription Program (CMPP).
  • The CMPP is a prescription discount card program that provides Costco members and their eligible dependents with the ability to obtain lower prices on prescription products.
  • For home delivery, Costco members can receive the CMPP's discount pricing by purchasing POGO Automatic online from Costco's mail order pharmacy.
  • Intuity Medical's POGO Automatic Blood Glucose Monitoring System is the only FDA-cleared automatic blood glucose monitoring system, or ABGM, that lances and collects blood in just one step with 10-test cartridge technology, ending the need to individually load lancets and test strips (as required by other blood glucose meters).